Anti-Integrin b2/ITGB2/CD18 Antibody (Erlizumab)
Catalog No.
F1585
Anti-Integrin b2/ITGB2/CD18 Antibody (Erlizumab)
Featured Products
Erlizumab is a CHO-expressed humanized antibody targeting Integrin b2/ITGB2/CD18. Erlizumab has a huIgG1-type heavy chain and a huκ-type light chain with a predicted molecular weight (MW) of 145 kDa.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
211323-03-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
rhuMAb CD18
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P08514
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Integrin b2 / ITGB2 / CD18
Please avoid freeze-thaw cycles.